Literature DB >> 16914094

ISG15 enhances the innate antiviral response by inhibition of IRF-3 degradation.

G Lu1, J T Reinert, I Pitha-Rowe, A Okumura, M Kellum, K P Knobeloch, B Hassel, P M Pitha.   

Abstract

The transcription factor, interferon regulatory Factor 3 (IRF-3) plays a critical role in the activation of an antiviral innate immune response. However the transcriptional activity of IRF-3 is tightly regulated by a proteosome mediated degradation. We describe here a novel mechanism by which the activity of IRF-3 is stabilized in infected cells. We have shown that both interferon treatment and NDV infection profoundly increase conjugation of interferon induced ubiquitin- like protein ISG15 to cellular proteins. ISGylated IRF-3 could be detected both in interferon treated and virus-infected cells. ISG15, subverts the ubiquitin mediated degradation of IRF-3 in NDV infected 2fTGH cells and enhances the NDV mediated transactivation of interferonbeta promoter and the translocation of activated IRF-3 to the nucleus. The relative levels of IRF-3 were significantly lower in NDV infected ISG15 null MEF, than in wt MEF. While ISG15 null MEF were more permissive to VSV replication their sensitivity to the antiviral effect of interferon was not modulated. These results reveal that virus mediated subversion of the antiviral response by proteolysis of IRF-3 is counteracted by induction of ISG15 expression and that ISGylation provides a feedback mechanism, which enhances the host innate antiviral response via IRF-3 stabilization.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16914094

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  63 in total

1.  Bovine herpesvirus 1 protein bICP0 represses the transcription of bISG15 in fetal bovine lung cells.

Authors:  Chang Liu; Xiao-Hong Kong; Wen-Tao Qiao; Yun-Qi Geng
Journal:  Virol Sin       Date:  2011-12-10       Impact factor: 4.327

2.  Two independent mechanisms promote expression of an N-terminal truncated USP18 isoform with higher DeISGylation activity in the nucleus.

Authors:  Christoph Burkart; Jun-Bao Fan; Dong-Er Zhang
Journal:  J Biol Chem       Date:  2011-12-14       Impact factor: 5.157

Review 3.  The IRF family, revisited.

Authors:  A Paun; P M Pitha
Journal:  Biochimie       Date:  2007-02-20       Impact factor: 4.079

Review 4.  Viral defense, carcinogenesis and ISG15: novel roles for an old ISG.

Authors:  Ian F Pitha-Rowe; Paula M Pitha
Journal:  Cytokine Growth Factor Rev       Date:  2007-08-03       Impact factor: 7.638

5.  ISG15 is counteracted by vaccinia virus E3 protein and controls the proinflammatory response against viral infection.

Authors:  Benedito Eduardo-Correia; Carles Martínez-Romero; Adolfo García-Sastre; Susana Guerra
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

Review 6.  Emerging roles for immunomodulatory functions of free ISG15.

Authors:  Jessica A Campbell; Deborah J Lenschow
Journal:  J Interferon Cytokine Res       Date:  2013-09-06       Impact factor: 2.607

7.  Caspase-8-mediated cleavage inhibits IRF-3 protein by facilitating its proteasome-mediated degradation.

Authors:  Nathaniel Sears; Ganes C Sen; George R Stark; Saurabh Chattopadhyay
Journal:  J Biol Chem       Date:  2011-08-04       Impact factor: 5.157

Review 8.  Functions of the cytoplasmic RNA sensors RIG-I and MDA-5: key regulators of innate immunity.

Authors:  Paola M Barral; Devanand Sarkar; Zao-zhong Su; Glen N Barber; Rob DeSalle; Vincent R Racaniello; Paul B Fisher
Journal:  Pharmacol Ther       Date:  2009-07-15       Impact factor: 12.310

Review 9.  Collaboration of Toll-like and RIG-I-like receptors in human dendritic cells: tRIGgering antiviral innate immune responses.

Authors:  Attila Szabo; Eva Rajnavolgyi
Journal:  Am J Clin Exp Immunol       Date:  2013-10-16

10.  Sustained activation of interferon regulatory factor 3 during infection by paramyxoviruses requires MDA5.

Authors:  Nathalie Grandvaux; Xiaochun Guan; Fabrice Yoboua; Nicolas Zucchini; Karin Fink; Priscilla Doyon; Lydie Martin; Marc J Servant; Stéfany Chartier
Journal:  J Innate Immun       Date:  2014-04-30       Impact factor: 7.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.